Cardiology Development Hormones Research 
Scienmag
SEPTEMBER 27, 2020
Yale physician to discuss the most promising developments in estrogen therapy, including new fetal estrogens, during the 2020 NAMS Virtual Annual Meeting Pre-Meeting Symposium CLEVELAND, Ohio (September 28, 2020)–Hormone therapy remains the best proven method for managing menopause symptoms such as hot flashes.
The Pharma Data
FEBRUARY 21, 2022
At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients. “We
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Delveinsight
DECEMBER 29, 2020
Myovant Sciences have decided to put their forces and efforts together to advance the Prostate cancer market as they announced their partnership deal to develop and market relugolix for prostate cancer and women’s health. . Relugolix is a once-daily, oral gonadotropin-release hormone (GnRH) receptor antagonist. The post A USD 4.2
The Pharma Data
APRIL 1, 2021
“Diabetes is a complex condition, and each specialty should be prioritizing their patients’ overall health and developing treatment plans in collaboration with other specialists without worrying of overstepping,” said Javed Butler, M.D., The findings are from a survey of 1,000 U.S. healthcare professionals (i.e.,
XTalks
NOVEMBER 19, 2021
While cardiac biomarkers hold much promise, there are a number of challenges in developing robust markers that can accurately reflect changes in disease biology linked to the mechanism of action of a therapeutic intervention. This is a part of the precision cardiology approach and could lead to their use as prognostic indicators.
XTalks
AUGUST 2, 2023
We delve into the driving forces behind their successes and shed light on the groundbreaking research that has earned them a place among the elite in the pharmaceutical arena. is a global pharmaceutical company, working across both developed and emerging markets. Pfizer Inc. The private sector price of Prevnar 20 is around $253.96
The Pharma Data
DECEMBER 1, 2020
The researchers found that increased greenness and air quality reduced cardiovascular disease mortality. The researchers found that increased adherence to healthy lifestyle behaviors was associated with lower all-cause mortality, regardless of medication burden. ” Press Release. ” Press Release. percent among U.S.
Expert insights. Personalized for you.
49 
Let's personalize your content